Bladder Cancer Indication Withdrawn for Durvalumab ...Middle East

News by : (Medscape) -
AstraZeneca is withdrawing durvalumab's indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Bladder Cancer Indication Withdrawn for Durvalumab )

Also on site :

Most Viewed News
جديد الاخبار